submitted Marketing Authorization

Related by string. * submitting . Submitting . submitter : - -ON SLAUGHTER DATA SUBMITTED . ON SLAUGHTER DATA SUBMITTED . submitted Biologics License / marketing . markets . market : MARKET WIRE via COMTEX . Stock Market . RBC Capital Markets / authorizations . Authorizations . AUTHORIZATION : share repurchase authorization . repurchase authorization . explicit authorization * *

Related by context. Frequent words. (Click for all words.) 85 submitted Biologics License 81 Application MAA 66 Crucell NV Euronext 66 NASDAQ CRXL 66 Application BLA 66 FDA Accepts 64 R sorafenib tablets 64 ZALBIN 63 NASDAQ SHPGY 63 Positive Opinion 62 Orphan Drug designation 62 Medicinal Products EMEA 62 Marketing Authorization Application MAA 62 Presents Positive 61 Generic Version 61 Marketing Authorization 61 Act PDUFA date 60 Actelion Ltd 60 refractory chronic lymphocytic 60 orphan medicinal product 60 Completes Enrollment 60 Marketing Authorization Application 60 Marketing Authorisation 60 Nexavar ® 59 Idera Pharmaceuticals 59 Drug Candidate 59 Loramyc R 59 Pirfenidone 59 Orphan Drug status 59 Recombinant Human 59 Merck Serono division 59 Company Nasdaq PRGO 59 HAYWARD Calif. BUSINESS WIRE 59 SCHWARZ PHARMA 58 Inc. Nasdaq IMGN 58 supplemental Biologics License Application 58 Genelabs Technologies Inc. 58 Orphan Medicinal Product 58 Inc Therapeutic Competitors 58 Merck KGaA Darmstadt Germany 58 Inc. Nasdaq SEPR 58 Clinical Trials Update 58 Transcept Pharmaceuticals 58 FDA Clears 58 Receives Patent 58 orphan designation 58 BioDelivery Sciences 58 Orphan Drug Status 58 European Medicines Evaluation 57 Ambrisentan 57 Xyzal 57 Director Shareholding 57 Pivotal Phase III 57 Alitretinoin 57 Initiates Phase 57 Orphan Drug 57 Panzem R 57 Patent Issued 57 Oscient Pharmaceuticals Corporation 57 Orphan Drug Designation 57 PRIALT 57 Patent Covering 57 Nasdaq VRTX 57 Icatibant 56 NASDAQ OSIR 56 Janssen Pharmaceutica NV 56 Patient Enrollment 56 Vimovo 56 IMPAX Laboratories Inc. 56 Zalbin 56 www.gsk.com 56 Announces FDA Clearance 56 Exalgo 56 Portola Pharmaceuticals 56 Nasdaq BDSI 56 Inc. Nasdaq MYL 56 Rotarix R 56 Clinical Trial Results 56 Connetics Corporation 56 Surgical Adhesive 56 silodosin 55 Mutual Recognition Procedure 55 NASDAQ LGND 55 Fresenius Kabi AG 55 ISTA Pharmaceuticals 55 desvenlafaxine 55 Nasdaq ENZN 55 ticker symbol OPERA 55 Phase III Clinical Trial 55 Files Shelf Registration Statement 55 Pulmonary Arterial Hypertension 55 FDA approvable letter 55 EntreMed Inc. 55 Belimumab 55 received CE Marking 55 Australian Therapeutic Goods 55 Cholesterol Drug 55 granted Orphan Drug 55 EPIX Pharmaceuticals Inc. 55 Single Dose 55 pSivida Limited

Back to home page